NovaBridge Biosciences (NBP) Debt Ratio (2018 - 2023)

NovaBridge Biosciences (NBP) has reported Debt Ratio for 4 consecutive years, with 0.01 the latest figure, recorded in Q4 2023.

• In Q4 2023, Debt Ratio rose 146.49% year-over-year to 0.01; the TTM figure through Dec 2023 stood at 0.01 (up 146.49% YoY), while the FY2023 annual figure was 0.01, up 146.93% from the prior year.
• Debt Ratio grew to 0.01 in Q4 2023 per NBP's latest filing, from 0.01 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.03 in Q4 2019 and bottomed at 0.0 in Q4 2022.
• Historically, Debt Ratio has averaged 0.01 across 3 years, with a median of 0.01 in 2023.
• Annual changes were most pronounced in 2019 — Debt Ratio dropped 14.54% — and 2023, when it jumped 146.49%.
• NovaBridge Biosciences' Debt Ratio stood at 0.03 in 2019, then tumbled by 83.83% to 0.0 in 2022, then surged by 146.49% to 0.01 in 2023.
• Business Quant data shows NBP's Debt Ratio at 0.01 in Q4 2023, 0.01 in Q2 2023, and 0.0 in Q4 2022.